S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|New Data from ENDORSE Show Positive Results Continued over Five Years with TECFIDERA® (Dimethyl Fumarate) in a Wide Range of Multiple Sclerosis Patients|
|Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA™ (Daclizumab High-Yield Process)|
|Rose Rock Midstream, L.P. Announces Pricing of $400 Million of 5.625% Senior Notes|
|PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis|
|Rose Rock Midstream Closed Transaction to Acquire Transportation Assets From Chesapeake|
|White Cliffs Pipeline, L.L.C. Begins Commissioning of White Cliffs Pipeline Expansion|
|SemGroup Corporation and Rose Rock Midstream, L.P. Announce Timing of Second Quarter 2014 Earnings Conference Call and Webcast|
|Rose Rock Midstream, L.P. Increases Distributions on Limited Partner Units|
|Data to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment to Developing Solutions to Meet the Needs of the Multiple Sclerosis Community|
|Biogen Idec Data at Joint ACTRIMS-ECTRIMS Meeting Highlight Robust Multiple Sclerosis Portfolio and Commitment to Advancing Patient Care|
Click above to view more mutual fund data and stats for rrm - Ross River Minerals Inc.